Atrial Fibrillation

Featured Article
Bleeding Events, Hospitalizations Among Patients with AF
Blake Charlton, MD a clinical fellow at the University of California, San Francisco School of Medicine, discusses his recent study that examined how NOACs and warfarin impact patients with atrial fibrillation differently.
Apixaban Effective in AF Patients Scheduled for Cardioversion
Researchers recently examined the safety and efficacy of apixaban for anticoagulation in patients with atrial fibrillation scheduled for cardioversion.
Drug Raises Mortality Risk in Patients with AF
A drug is associated with an increased risk of mortality among patients with atrial fibrillation with and without heart failure, recent research suggests.

Newsfeed

Bleeding Events, Hospitalizations Among Patients with AF
Apixaban Effective in AF Patients Scheduled for Cardioversion
Drug Raises Mortality Risk in Patients with AF
Preventing Sudden Death in AF Patients
What’s the Best Treatment for AF Patients With Major Bleeding Event?
Beta-Blockers' Value for Heart Failure with A-Fib Reaffirmed
Which Anticoagulant Can Reduce Risk of Drug-Drug Interactions?
Updated Guidelines for Atrial Fibrillation
View More

Interactive Features

Calcium Channel Blockers Improve Exercise Capacity in Atrial Fibrillation
Calcium channel blockers improve exercise capacity in patients with permanent atrial fibrillation (AF), but beta-blockers have the opposite effect, according to a new study from Norway.
View More
Back to Top